Dr. Björn Cochlovius

Dr. Björn Cochlovius has gained considerable experience in the biotech and pharmaceutical industry in more than 25 years of academic and industrial leadership. His responsibilities included R&D, product development and strategic functions (business development, strategy, etc.).

Furthermore, as an independent consultant among others, he has assisted in trade sales, IPOs and M&As. He is co-founder of several biotech companies. Finally, he has extensive international experience (e.g. Switzerland, Scandinavia, Asia).
Mr. Cochlovius studied molecular biology, wrote his PhD (Dr.rer.nat.) at the German Cancer Research Center DKFZ, Heidelberg. He completed his habilitation at the Medical Faculty of the University of Heidelberg. He has worked for pharmaceutical companies such as Roche, Otsuka, Abbvie.